共 50 条
- [23] Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas ANNALS OF HEMATOLOGY, 2020, 99 (09) : 2125 - 2132
- [30] C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases JOURNAL OF CANCER, 2020, 11 (01): : 190 - 198